Systematic review of the prevalence and incidence of Parkinson’s disease in the People’s Republic of China

Código QR

Systematic review of the prevalence and incidence of Parkinson’s disease in the People’s Republic of China

Yong-ming Zou,1 Jia Liu,2 Zhi-yan Tian,1 Da Lu,1 Yu-ying Zhou1 1Department of Neurology, TianJin HuangHu Hospital, TianJin, People’s Republic of China; 2Department of Neurology, Xuan Wu Hospital, Beijing, People’s Republic of China Background: Parkinson’s disease (PD)...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zou YM, Liu J, Tian ZY, Lu D, Zhou YY
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/e0c4007c375b483db83b7025c3fc6cbf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Do physical exercise and reading reduce the risk of Parkinson’s disease? a cross-sectional study on factors associated with Parkinson’s disease in elderly Chinese veterans
por: Zou YM, et al.
Publicado: (2015)

A cross-sectional study on anxiety and stress in pregnant women with chronic HBV infection in the People’s Republic of China
por: Zhou F, et al.
Publicado: (2015)

The cost reduction in hospitalization associated with paliperidone palmitate in the People’s Republic of China, Korea, and Malaysia
por: Chiou CF, et al.
Publicado: (2015)

Social phobia in Parkinson’s disease: Prevalence and risk factors
por: Gultekin BK, et al.
Publicado: (2014)

Prevalence of Parkinson’s disease and other types of Parkinsonism in Al Kharga district, Egypt
por: El-Tallawy HN, et al.
Publicado: (2013)

Investigation on Internet addiction disorder in adolescents in Anhui, People’s Republic of China
por: Chen Y, et al.
Publicado: (2016)

Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People’s Republic of China
por: Wu J, et al.
Publicado: (2015)

Rasagiline in treatment of Parkinson&rsquo;s disease
por: Lakshmi Nayak, et al.
Publicado: (2008)

Parkinson’s disease-associated melanin steal
por: Hinz M, et al.
Publicado: (2014)

Sleep disorders in Parkinson&rsquo;s disease
por: Israt Jahan, et al.
Publicado: (2009)

Olfactory dysfunction in Alzheimer’s disease
por: Zou YM, et al.
Publicado: (2016)

High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People’s Republic of China
por: Xiao JB, et al.
Publicado: (2015)

Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden
por: Modugno N, et al.
Publicado: (2020)

Current approaches to the treatment of Parkinson&rsquo;s disease
por: Joseph Jankovic, et al.
Publicado: (2008)

Update on ropinirole in the treatment of Parkinson&rsquo;s disease
por: Holly A Shill, et al.
Publicado: (2008)

Ceruloplasmin and iron in Alzheimer&rsquo;s disease and Parkinson&rsquo;s disease: a synopsis of recent studies
por: Kristinsson J, et al.
Publicado: (2012)

Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA
por: Tu L, et al.
Publicado: (2020)

Rivastigmine for the treatment of dementia associated with Parkinson&rsquo;s disease
por: Jennifer L Reingold, et al.
Publicado: (2007)

Update on the use of pramipexole in the treatment of Parkinson&rsquo;s disease
por: Radu Constantinescu
Publicado: (2008)

Parkinson&rsquo;s disease and the frequent reasons for emergency admission
por: Ozlem Guneysel, et al.
Publicado: (2008)

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
por: Bargiotas P, et al.
Publicado: (2013)

Relationship between suicide rate and economic growth and stock market in the People’s Republic of China: 2004–2013
por: Yin HL, et al.
Publicado: (2016)

Comparative study of the influence of diabetes distress and depression on treatment adherence in Chinese patients with type 2 diabetes: a cross-sectional survey in the People’s Republic of China
por: Zhang J, et al.
Publicado: (2013)

Psychiatric disorders in primary focal dystonia and in Parkinson&rsquo;s disease
por: Fernando MV Dias, et al.
Publicado: (2011)

Potential cellular and regenerative approaches for the treatment of Parkinson&rsquo;s disease
por: Emma L Lane, et al.
Publicado: (2008)

Neuropsychiatric symptoms in untreated Parkinson’s disease
por: Szatmari S, et al.
Publicado: (2017)

Parkinson&rsquo;s disease patients&rsquo; subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life
por: Skogar &Ouml;, et al.
Publicado: (2012)

Depression in Parkinson&rsquo;s disease: Health risks, etiology, and treatment options
por: Pasquale G Frisina, et al.
Publicado: (2008)

The impact of nocturnal disturbances on daily quality of life in patients with Parkinson’s disease
por: Yu RL, et al.
Publicado: (2015)

Beneficial effect of pramipexole for motor function and depression in Parkinson&rsquo;s disease
por: Osamu Kano, et al.
Publicado: (2009)

A randomized controlled trial of quetiapine for psychosis in Parkinson&rsquo;s disease
por: Paul Shotbolt, et al.
Publicado: (2009)

Wearing-off in Parkinson’s disease: neuropsychological differences between on and off periods
por: Caillava-Santos F, et al.
Publicado: (2015)

Depressive symptoms in Parkinson&rsquo;s disease and in non-neurological medical illnesses
por: Assogna F, et al.
Publicado: (2013)

Parkinson’s Disease-Associated Melanin Steal [Retraction]
por: Hinz M, et al.
Publicado: (2021)

Cytological and cytometric analysis of oral mucosa in patients with Alzheimer’s and Parkinson’s disease
por: Kose Ozlece H, et al.
Publicado: (2018)

Did depressive symptoms affect recognition of emotional prosody in Parkinson&rsquo;s disease?
por: Adriana V&eacute;lez Feij&oacute;, et al.
Publicado: (2008)

Asymmetry of Subthalamic Neuronal Firing Rate and Oscillatory Characteristics in Parkinson’s Disease [Retraction]
por: Zhao XM, et al.
Publicado: (2020)

Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People’s Republic of China
por: Zhang L, et al.
Publicado: (2016)

Update on the treatment of Parkinson’s disease psychosis: role of pimavanserin
por: Combs BL, et al.
Publicado: (2017)

Parkinson’s disease managing reversible neurodegeneration
por: Hinz M, et al.
Publicado: (2016)